To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

High-Energy Focused Extracorporeal Shockwave Therapy for Preventing Glucocorticoid-Induced ONFH

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
December 2022

High-Energy Focused Extracorporeal Shockwave Therapy for Preventing Glucocorticoid-Induced ONFH

Vol: 302| Issue: 4| Number:3| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

High-energy focused extracorporeal shock wave prevents the occurrence of glucocorticoid-induced osteonecrosis of the femoral head: A prospective randomized controlled trial

J Orthop Translat. 2022 Oct 6;36: 145-151.

Contributing Authors:
X Yang L Shi T Zhang F Gao W Sun P Wang X Wu Z Li

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

One hundred and fifty-four patients receiving high-dose glucocorticoid therapy who were at risk of osteonecrosis of the femoral head were randomized to receive a single session of high-energy focused extracorporeal shockwave therapy (n=75) or control (n=79), in addition to 6 weeks of pharmaceutical intervention (alendronate sodium; Chinese herbal medicine). Outcomes of interest included Visual Ana...

Join the Conversation

Please Login or Join to leave comments.